Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,881.30 +909.38 (+1.44%) CMC Crypto 200
1,327.33 +50.35 (+3.94%)
Pyxis Oncology, Inc. (PYXS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 257.88M |
| Enterprise value | 159.91M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.05 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.99 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.51 |
| 52-week change 3 | 47.00% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 6.8500 |
| 52-week low 3 | 1.3500 |
| 50-day moving average 3 | 5.0696 |
| 200-day moving average 3 | 2.9832 |
Share statistics
| Avg vol (3-month) 3 | 753.39k |
| Avg vol (10-day) 3 | 388k |
| Shares outstanding 5 | 58.88M |
| Implied shares outstanding 6 | 59.28M |
| Float 8 | 35.69M |
| % held by insiders 1 | 20.23% |
| % held by institutions 1 | 29.80% |
| Shares short (15 Apr 2024) 4 | 2.21M |
| Short ratio (15 Apr 2024) 4 | 2.52 |
| Short % of float (15 Apr 2024) 4 | 4.56% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.80% |
| Shares short (prior month 15 Mar 2024) 4 | 1.63M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -26.10% |
| Return on equity (ttm) | -51.51% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -78.49M |
| Net income avi to common (ttm) | -73.79M |
| Diluted EPS (ttm) | -1.8500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 119.3M |
| Total cash per share (mrq) | 2.05 |
| Total debt (mrq) | 21.33M |
| Total debt/equity (mrq) | 16.97% |
| Current ratio (mrq) | 4.84 |
| Book value per share (mrq) | 2.81 |
Cash flow statement
| Operating cash flow (ttm) | -70.71M |
| Levered free cash flow (ttm) | -43.21M |
© 2024 Yahoo. All rights reserved.